Cart
sales@molnova.com
Home -
Products -
Proteasome/Ubiquitin -
Endogenous Metabolite -
2-(1-methyl-1H-imidazol-4-yl)acetic acid
2-(1-methyl-1H-imidazol-4-yl)acetic acid
CAS No. 2625-49-2
2-(1-methyl-1H-imidazol-4-yl)acetic acid( —— )
Catalog No. M37575 CAS No. 2625-49-2
2-(1-methyl-1H-imidazol-4-yl)acetic acid (2-(1-methylimidazol-4-yl)acetic acid) is a plasma histamine derivative that is a biomarker for identifying lymphangioleiomyomatosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 123 | In Stock |
|
| 5MG | 187 | In Stock |
|
| 10MG | 277 | In Stock |
|
| 25MG | 454 | In Stock |
|
| 50MG | 659 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name2-(1-methyl-1H-imidazol-4-yl)acetic acid
-
NoteResearch use only, not for human use.
-
Brief Description2-(1-methyl-1H-imidazol-4-yl)acetic acid (2-(1-methylimidazol-4-yl)acetic acid) is a plasma histamine derivative that is a biomarker for identifying lymphangioleiomyomatosis.
-
Description2-(1-methyl-1H-imidazol-4-yl)acetic acid (2-(1-methylimidazol-4-yl)acetic acid) is a plasma histamine derivative that is a biomarker for identifying lymphangioleiomyomatosis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayProteasome/Ubiquitin
-
TargetEndogenous Metabolite
-
RecptorEndogenous Metabolite
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2625-49-2
-
Formula Weight140.14
-
Molecular FormulaC6H8N2O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(O)CC=1N=CN(C1)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Tiglyl carnitine
Tiglyl carnitine is associated with lung cancer and carnitine and glycine to 3-ketothiolase deficiency .
-
2-Phenylglycine
2-Phenylglycine is a metabolite in breast milk during the lactation period.
-
Coenzyme Q9
Coenzyme Q9 (CoQ9) is a normal constituent of human plasma.?CoQ9 in human plasma may originate as a product of incomplete CoQ10 biosynthesis or from the diet.
